News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
International Drug & Explosives Detection Firm IDenta Corporation Issues New Statement Concerning Buy-Out Discussions With U.S. Corporation
June 28, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
JERUSALEM, ISRAEL--(MARKET WIRE)--Jun 28, 2007 -- The CEO of IDenta Corp. (Other OTC:IDTA.PK - News) issued a statement today that provides some additional information on Tuesday's official statement concerning recent buy-out and merger offers.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Asia
MORE ON THIS TOPIC
Mergers & acquisitions
Pfizer Beat Out Two Other Metsera Suitors for Takeover
October 7, 2025
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Chiesi, Arbor Weave $2.1B Rare Disease Pact
October 6, 2025
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
October 2, 2025
·
3 min read
·
Annalee Armstrong
Mergers & acquisitions
Halozyme’s $900M Elektrofi Buyout Brings Two Big Pharma Partners Together
October 2, 2025
·
2 min read
·
Tristan Manalac